Impact of Minimal Residual Disease on Progression-Free Survival Outcomes After Fixed-Duration Ibrutinib-Venetoclax Versus Chlorambucil-Obinutuzumab in the GLOW Study von Munir, Talha, Moreno, Carol, Owen, Carolyn, Follows, George, Benjamini, Ohad, Janssens, Ann, Levin, Mark-David, Osterborg, Anders, Robak, Tadeusz, Simkovic, Martin, Stevens, Don, Voloshin, Sergey, Vorobyev, Vladimir, Yagci, Munci, Ysebaert, Loic, Qi, Keqin, Qi, Qianya, Parisi, Lori, Srinivasan, Srimathi, Schuier, Natasha, Baeten, Kurt, Howes, Angela, Caces, Donne Bennett, Niemann, Carsten U, Kater, Arnon P

Volltext

SURECAP: Survey and Evaluation of Castration Resistant Prostate Cancer (CRPC) von Merseburger, A.S, Kellermann, L, Janitzky, A, Hatzinger, M, Feyerabend, S, Luetter, C, Kruetzfeldt, K, Schuier, N, Tran, N

Volltext

Prospective, non-interventional study on the influence of adherence measures on the therapy with Abiraterone Acetate (AA) + Prednisone/prednisolone (P) in patients with metastatic,... von Suttmann, H, Feyerabend, S, Gleissner, J, Huebner, A, Neugebauer, E, Mathes, T, Baurecht, W, Schuier, N, Tran, N

Volltext

P081 - Prospective, non-interventional study on the influence of adherence measures on the therapy with Abiraterone Acetate (AA) + Prednisone/prednisolone (P) in patients with meta... von Suttmann, H., Feyerabend, S., Gleissner, J., Huebner, A., Neugebauer, E., Mathes, T., Baurecht, W., Schuier, N., Tran, N.

Volltext

P080 - SURECAP: Survey and Evaluation of Castration Resistant Prostate Cancer (CRPC) von Merseburger, A.S., Kellermann, L., Janitzky, A., Hatzinger, M., Feyerabend, S., Luetter, C., Kruetzfeldt, K., Schuier, N., Tran, N.

Volltext